Celularity Inc
NASDAQ:CELU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celularity Inc
NASDAQ:CELU
|
US |
|
Addus Homecare Corp
NASDAQ:ADUS
|
US |
|
T
|
TQM Alpha PCL
SET:TQM
|
TH |
|
Americold Realty Trust
NYSE:COLD
|
US |
|
United Tractors Tbk PT
OTC:PUTKY
|
ID |
|
M
|
Motus Holdings Ltd
JSE:MTH
|
ZA |
|
Mattel Inc
NASDAQ:MAT
|
US |
|
L
|
L'Oreal SA
DUS:LOR
|
FR |
|
FreightCar America Inc
NASDAQ:RAIL
|
US |
|
S
|
Shandong Hi-Speed Holdings Group Ltd
F:HRI
|
HK |
|
C
|
Compagnie d'entreprises CFE SA
XBRU:CFEB
|
BE |
|
E
|
Entegris Inc
XMUN:ENQ
|
US |
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
KR |
|
Innospec Inc
NASDAQ:IOSP
|
US |
|
M
|
Mitsubishi Chemical Group Corp
F:M3C0
|
JP |
|
Confluent Inc
NASDAQ:CFLT
|
US |
|
Paleo Resources Inc
XTSX:PRE
|
CA |
|
Adeia Inc
NASDAQ:ADEA
|
US |
Bankruptcy Probability
Celularity Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celularity Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Celularity Inc
NASDAQ:CELU
|
25.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celularity Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celularity Inc has total debt of 34.2m USD. This includes both short-term (0 USD) and long-term (34.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
